⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.

SELANK

A 7-amino acid synthetic heptapeptide derived from tuftsin that modulates GABAergic neurotransmission and BDNF expression, studied for anxiolytic and nootropic effects in clinical research. Premium Research Peptide.

USD29.95

BUNDLE & SAVE

1 BOTTLE
2 BOTTLES
5% OFF
BEST VALUE
3+ BOTTLES
7.5% OFF

*Discount will be automatically applied in cart

🚚 Estimated delivery: Loading...
🛡️ Free shipping protection on every order
Same-day dispatch on orders before 2 PM EST

Free Shipping

on orders over $200

Damage protection

every order covered

Secure checkout

256-bit SSL

Every batch, independently verified.

Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory.
The report below reflects the identity, purity and full-panel specification data released with this product.
ILS Laboratories
Certificate of Analysis
99 %
Purity by HPLC
ISO 17025 Accredited 8× Tested
ParameterResultSpecification
AppearanceGoodMeets spec
Purity99.49% · Pass≥ 95%
Net Peptide Content10.62mgReport
IdentityConfirmedMeets spec
Fentanyl ScreenNot DetectedPass
Heavy MetalsNot DetectedPass
SterilityNo GrowthPass
Endotoxin< 0.05 EU/mLReported

Compound Information

Technical specifications

Molecular Profile

What Is Selank?

Synthetic heptapeptide analog of tuftsin, an immunomodulatory tetrapeptide derived from IgG

Type

Synthetic heptapeptide

CAS Number

129954-34-3

 

Molecular Weight

751.9 g/mol

Amino Acids

7 residues

Formula

C33H57N11O9

Sequence

Thr-Lys-Pro-Arg-Pro-Gly-Pro
Storage Requirements

Stability Information

Handle with care to maintain potency

Lyophilized (powder)

-20°C • protect from light

Reconstituted

2-8°C

Nasal spray

2-8°C • 30 days after opening

Development Status

Regulatory Information

Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences

Developer

Russian Academy of Sciences

Collaborator

V.V. Zakusov Institute

Approval

Russia (2009), Ukraine

Indication

Generalized Anxiety Disorder

US Status

Not FDA-approved

Formulation

0.15% nasal drops (Rx in Russia)
⚠️ IMPORTANT RESEARCH NOTICE

Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.

All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.